在不列颠哥伦比亚省长期COVID患者的康复需求
Débora M Petry Moecke1,2, Evan H Kwong3, Sonya Cressman4
1Centre for Heart Lung Innovations, University of British Columbia, Vancouver, British Columbia, Canada.
PM & R : the journal of injury, function, and rehabilitation
|January 28, 2026
概括
大多数长期COVID患者需要康复,其中98%需要因疲劳,呼吸困难和功能减弱等问题提供服务. 肺部,精神健康和神经康复最常需要.
科学领域:
- 康复医学 康复医学 康复医学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 长期COVID,以COVID-19感染后的持续症状为特征,严重损害了日常功能.
- 了解长期COVID患者所需的康复程度和类型至关重要.
- 目前关于这一群体康复需求的数据仍然有限.
研究的目的:
- 估计长期COVID患者所需的患病率和康复类型.
- 识别特定的症状和功能障碍,表明需要康复.
主要方法:
- 来自加拿大不列颠哥伦比亚省一家COVID后康复诊所的临床数据的回顾性,横截面分析.
- 纳入标准:感染后症状持续超过3个月的个体,在6个月内访问诊所.
- 根据客观测试和患者报告的结果,使用预定义的门来确定康复需求.
主要成果:
- 分析包括1237名符合条件的患者 (33%的3709初始记录);主要是女性 (65%),平均年龄49岁.
- 对于呼吸障碍 (83%),疲劳 (78%),虚弱 (74%) 和PTSD (58%) 观察到高康复需求.
- 98%的患者超过至少一个康复门; 85%有资格接受多种类型的治疗,主要是肺部 (83%),心理健康 (78%) 和神经康复 (70%).
结论:
- 在不列颠哥伦比亚省的长期COVID患者中存在大量的康复服务需求.
- 预先定义的门,将症状负担和功能障碍整合起来,有效地识别需要专门护理的患者.
- 这种方法促进了及时,基于证据的转诊,改善了患者的治疗结果.
更多相关视频
相关概念视频
Patient-centered Care
3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Geriatric Patients
232
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
232
Drug Dosing: Obese Patients
254
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254
Pharmacodynamics in Geriatric Patients: Effects of Age
202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285


